IVD Approved RT-PCR Kit

Drawbacks of the Real-Time RT-PCR for diagnoses of COVID-19

Short Detection Time: In cases of Oncology and genetic disorders and even infectious communicable diseases, only indicate the presence of the viral material during the infection. It will not assess if the person was infected or whether they have developed immunity and recovered.

Advertisements

The negative results are not exclusive to the COVID-19 infection; therefore, the medical professional must not use them as a test for patient management decisions.

May Have High False-Negative Rates: The rates may be high due to improper collection and variable viral presence in the specimen. It may also happen due to the fact of amplification inhibitors. So, most of the cases may remain negative. Other multiple samples may also help to detect the virus.

Costly and Not Readily Scalable: The tests are specialized and need special bio-containment labs. These labs need trained techs who know how to run the test and can monitor the process to ensure no faults in the Human Papilloma Virus (HPV Detection).

The In-Vitro Tests

The other type of test of real-time PCR that the technicians can conduct is the in-vitro one. They perform these tests on the samples they take from the patients. They do so to run tests for their reproductive health or vector-borne transmission detection.

The samples are taken from the patients with the help of swabs from the back of their nose, mouth, or throat. The sample can also be blood drawn from the fingertip. The IVDs can monitor the patient’s overall health and thus cure and prevent diseases given their diagnosis and health condition.

Types of IVDs

Several IVDs are related to the SARS-CoV-2 and COVID-19:

  • Diagnostic Tests: The professionals can use the test to diagnose infection with the SARS-CoV-2 virus. The tests are molecular ones, nucleic acid amplification tests, and other diagnostic tests that analyze the breath samples.
  • Serology/ Other Adaptive Immune Response Tests: These tests detect the antibodies in the patient to the SARS-CoV-2 virus. They measure an alternative adaptive immune system like the T-cells to the virus. They cannot identify a current infection.
  • Tests to Manage COVID-19 Patients: Beyond the detection tests, other types of tests also help manage patients who have COVID-19. It detects the biomarkers related to inflammation. After their diagnosis of COVID-19 disease, these additional tests can inform patient management decisions in the respiratory disease diagnostic solutions.